Thomas J. Shaw Buys 21,142 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 21,142 shares of Retractable Technologies stock in a transaction that occurred on Wednesday, October 23rd. The shares were bought at an average price of $0.74 per share, for a total transaction of $15,645.08. Following the transaction, the chief executive officer now owns 14,794,794 shares of the company’s stock, valued at $10,948,147.56. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Retractable Technologies Stock Performance

NYSE:RVP opened at $0.73 on Friday. The company’s 50-day moving average is $0.84 and its two-hundred day moving average is $1.00. Retractable Technologies, Inc. has a 1-year low of $0.71 and a 1-year high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. The firm has a market capitalization of $21.88 million, a price-to-earnings ratio of -2.81 and a beta of 2.06.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. The business had revenue of $6.03 million for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Retractable Technologies in a report on Saturday. They set a “hold” rating on the stock.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.